跳至主要内容
临床试验/ACTRN12621000694819
ACTRN12621000694819招募中3 期

Effect of Ageratum conyzoides on osteoarthritis in an ageing adult population: A double-blind randomized placebo-controlled parallel study.

RDC Global Pty Ltd0 个研究点目标入组 80 人开始时间: 2021年6月7日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
45 Years 至 o limit(—)
性别
All

入选标准

  • Adults aged 45 years and above
  • Clinical diagnosis of osteoarthritis by a health professional
  • Reporting joint pain (not associated with acute injury, long-standing disease [other than osteoarthritis] or prescription medication use): equal to or greater than 10mm on visual analogue scale (VAS) for pain
  • BMI equal to or less than 35
  • Able to provide informed consent
  • Agree not to change current diet and exercise program while enrolled in this trial
  • Agree not to undertake another clinical trial while enrolled in this trial

排除标准

  • Unstable or serious illness (e.g. Serious mood disorders, neurological disorders such as MS, kidney disease, liver disease, heart conditions, diabetes, thyroid gland dysfunction)*
  • Current malignancy (excluding BCC) or chemotherapy and radiotherapy treatment for malignancy within the previous 2 years
  • Clinically significant acute or chronic inflammation, or connective tissue disease including, but not limited to, rheumatoid arthritis, tendinitis, bursitis, fibromyalgia or gout.
  • A history of knee or hip surgery and/or trauma within the previous 12 months
  • Receiving/prescribed coumandin (Warfarin), heparin, daltaparin, enoxaparin or other anticoagulation therapy
  • Receiving treatment for joint pain including but not limited to corticosteroid and hyaluronic acid use/injection, or taking supplements for joint pain/health such as glucosamine, chondroitin, curcumin and omega-3 containing products#.
  • Active smokers, nicotine use, alcohol or drug (prescription or illegal substances) abuse
  • Chronic past and/or current alcohol use (greater than 14 alcoholic drinks week)
  • Allergic to any of the ingredients in the active or placebo formula
  • Known pregnant or lactating woman
  • Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion
  • Participants who have participated in any other related clinical study during the past 1 month
  • History of infection in the month prior to the study
  • *An unstable illness is any illness that is currently not being treated with a stable dose of medication or is fluctuating in severity. A serious illness is a condition that carries a risk of mortality, negatively impacts quality of life and daily function and/or is burdensome in symptoms and/or treatments.
  • #Potential participants that are taking supplements that would result in their exclusion must wait a 4-week washout period prior to commencing the study.

研究者

相似试验